Loading clinical trials...
Loading clinical trials...
A Personalized Randomized Trial of Validation and Restoration of Immune Dysfunction in Severe Infections and Sepsis
Conditions
Interventions
Anakinra
Recombinant human interferon-gamma
+1 more
Locations
13
Greece
2nd Department of Critical Care Medicine
Athens, Haidari, Greece
4th Department of Internal Medicine
Athens, Haidari, Greece
Intensive Care Unit, Ioannina University Hospital
Ioannina, Ioannina, Greece
Intensive Care Unit, Center for Accident Rehabilitation (KAT) of Athens
Athens, Kifissia, Greece
Department of Internal Medicine, Patras University Hospital
Pátrai, Rion, Greece
Intensive Care Unit, Alexandroupolis University Hospital
Alexandroupoli, Greece
Start Date
December 15, 2017
Primary Completion Date
December 31, 2019
Completion Date
December 31, 2019
Last Updated
July 29, 2020
NCT04850456
NCT04955210
NCT07179276
NCT05267821
NCT07448805
NCT07351344
Lead Sponsor
Hellenic Institute for the Study of Sepsis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions